Biological effects of dental resin composites on human gingival fibroblasts: a systematic review of in vitro evidence
Clinical Oral Investigations · 2026
DOI: 10.1007/s00784-026-07149-3 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Clinical Oral Investigations, 2026. Verfasst von Elmira Boloori und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Gustav Mahler…. Hauptthemen laut MEDLINE: Gingiva, Fibroblasts, Composite Resins, Polyurethanes. Die Arbeit nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
This systematic review summarized and synthesized the in vitro biological effects of resin composites (RCs) on human gingival fibroblasts (HGFs) to clarify their isolated cellular biocompatibility. Materials and methods A systematic search was conducted in the MEDLINE/PubMed database using a PECOS framework to identify in vitro studies evaluating HGF responses to RCs. Two independent reviewers screened literature, extracted data, and assessed methodological quality (QUIN tool) and certainty of the evidence (GRADE framework).
Results
Thirty-eight studies comprising 185 distinct experiments across eight outcome measures were included. Marked heterogeneity was observed regarding RC composition (7 categories), specimen geometry, cell lines, and experimental durations. When evaluating cellular survival and damage independently, 27% of cytotoxicity experiments reported significant cell damage/death, while 45% of cell viability assays demonstrated a decreased metabolic activity. DNA damage was prominent, with 50% of 18 experiments reporting significant alterations. Significant increases occurred in reactive oxygen species production (71%) and inflammatory mediator release (62%). Conversely, 85% of morphology experiments showed no significant alterations. The overall certainty of evidence was graded as low to moderate.
Conclusion
Dental resin composites can induce notable, independent adverse biological responses in human gingival fibroblasts in vitro , characterized by oxidative stress, inflammatory mediator release, DNA damage, and compromised viability. While highlighting a clear potential for toxicity, the low-to-moderate certainty and lack of physiological simulations leave their direct clinical significance open to further investigation. Clinical relevance Synthesized evidence indicates that dental RCs exert moderate in vitro biological effects on gingival fibroblasts, including DNA-damage and inflammatory responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Gustav Mahlerlaan 3004, 1081, LA, Amsterdam, The Netherlands. e.boloori@acta.nl.
- Department of Periodontology, Academic Centre for Dentistry Amsterdam (ACTA), University of Amsterdam and Vrije Universiteit Amsterdam, Gustav Mahlerlaan 3004, 1081, LA, Amsterdam, The Netherlands.
Zitieren
APA
Boloori, E., Slot, D. E., Loos, B. G., de Vries, T. J., & van der Weijden, F. G. A. (2026). Biological effects of dental resin composites on human gingival fibroblasts: a systematic review of in vitro evidence. Clinical Oral Investigations. https://doi.org/10.1007/s00784-026-07149-3
Vancouver
Boloori E, Slot DE, Loos BG, de Vries TJ, van der Weijden FGA. Biological effects of dental resin composites on human gingival fibroblasts: a systematic review of in vitro evidence. Clinical Oral Investigations. 2026. doi:10.1007/s00784-026-07149-3
BibTeX
@article{Boloori2026,
author = {Boloori, Elmira and Slot, Dagmar E and Loos, Bruno G and de Vries, Teun J and van der Weijden, Fridus G A},
title = {Biological effects of dental resin composites on human gingival fibroblasts: a systematic review of in vitro evidence},
journal = {Clinical Oral Investigations},
year = {2026},
doi = {10.1007/s00784-026-07149-3}
}
EUVIMED